We are the leading CRO in zebrafish studies thanks to our more than 18 years of experience with this alternative model. During those years we have developed several validated assays on the areas of disease model generation, efficacy and toxicity carried to Pharma, Biotech, Chemical, Cosmetic, Nutraceutical, and Tobacco companies.

Apart from our Know-How another of our main values is Audacity because we are experts in listening to our customer’s needs to develop tailor-made solutions based on their requirements.

Also thanks to our automated and innovative tools, our validated assays are carried out with our High Content Screening (HCS) platform, allowing us to perform fast and cost-effective assays in zebrafish:
- Target Validation with Morpholinos or CRISPR/Cas13
- Zebrafish Disease Models: genetic mutations, transgenesis, and chemically induced models.
- Toxicity Assays: acute toxicity, neurotoxicity, developmental/teratogenic toxicity, cardiotoxicity, hepatotoxicity,
ototoxicity, immunotoxicity, nephrotoxicity, behavior alteration assay.
- Ecotoxicity Assays: Algal Microplate toxicity test, Daphnia magna immobilization assay, endocrine disruption
assay in zebrafish, and zebrafish larvae acute toxicity assay.
- Efficacy Assays: Oncology (angiogenesis inhibition assay, target validation, cancer models generation, xenograft
zebrafish embryos), CNS (Neuroprotection, Epilepsy, Parkinson, Alzheimer…), rare diseases, metabolism, immune
system, cardiovascular…
- Cosmetics: regeneration, melanin quantification, and antioxidant assays.